We provide you with 20 years of free, institutional-grade data for EXEL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EXEL. Explore the full financial landscape of EXEL stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-07-28 | 939767 | EXEL | 10-Q | Url |
| 2025-05-13 | 939767 | EXEL | 10-Q | Url |
| 2025-02-11 | 939767 | EXEL | 10-K | Url |
| 2024-10-29 | 939767 | EXEL | 10-Q | Url |
| 2024-08-06 | 939767 | EXEL | 10-Q | Url |
| 2024-04-30 | 939767 | EXEL | 10-Q | Url |
| 2024-02-06 | 939767 | EXEL | 10-K | Url |
| 2023-11-01 | 939767 | EXEL | 10-Q | Url |
| 2023-08-01 | 939767 | EXEL | 10-Q | Url |
| 2023-05-09 | 939767 | EXEL | 10-Q | Url |
| 2023-02-07 | 939767 | EXEL | 10-K | Url |
| 2022-11-01 | 939767 | EXEL | 10-Q | Url |
| 2022-08-09 | 939767 | EXEL | 10-Q | Url |
| 2022-05-10 | 939767 | EXEL | 10-Q | Url |
| 2022-02-18 | 939767 | EXEL | 10-K | Url |
| 2021-11-02 | 939767 | EXEL | 10-Q | Url |
| 2021-08-05 | 939767 | EXEL | 10-Q | Url |
| 2021-05-06 | 939767 | EXEL | 10-Q | Url |
| 2021-02-11 | 939767 | EXEL | 10-K | Url |
| 2020-11-05 | 939767 | EXEL | 10-Q | Url |
| 2020-08-06 | 939767 | EXEL | 10-Q | Url |
| 2020-05-05 | 939767 | EXEL | 10-Q | Url |
| 2020-02-25 | 939767 | EXEL | 10-K | Url |
| 2019-10-30 | 939767 | EXEL | 10-Q | Url |
| 2019-07-31 | 939767 | EXEL | 10-Q | Url |
| 2019-05-01 | 939767 | EXEL | 10-Q | Url |
| 2019-02-22 | 939767 | EXEL | 10-K | Url |
| 2018-11-01 | 939767 | EXEL | 10-Q | Url |
| 2018-08-01 | 939767 | EXEL | 10-Q | Url |
| 2018-05-02 | 939767 | EXEL | 10-Q | Url |
| 2018-02-26 | 939767 | EXEL | 10-K | Url |
| 2017-11-01 | 939767 | EXEL | 10-Q | Url |
| 2017-08-02 | 939767 | EXEL | 10-Q | Url |
| 2017-05-01 | 939767 | EXEL | 10-Q | Url |
| 2017-02-27 | 939767 | EXEL | 10-K | Url |
| 2016-11-03 | 939767 | EXEL | 10-Q | Url |
| 2016-08-03 | 939767 | EXEL | 10-Q | Url |
| 2016-05-04 | 939767 | EXEL | 10-Q | Url |
| 2016-02-29 | 939767 | EXEL | 10-K | Url |
| 2015-11-10 | 939767 | EXEL | 10-Q | Url |
| 2015-08-11 | 939767 | EXEL | 10-Q | Url |
| 2015-04-30 | 939767 | EXEL | 10-Q | Url |
| 2015-03-02 | 939767 | EXEL | 10-K | Url |
| 2014-11-04 | 939767 | EXEL | 10-Q | Url |
| 2014-07-31 | 939767 | EXEL | 10-Q | Url |
| 2014-05-01 | 939767 | EXEL | 10-Q | Url |
| 2014-02-20 | 939767 | EXEL | 10-K | Url |
| 2013-10-30 | 939767 | EXEL | 10-Q | Url |
| 2013-08-06 | 939767 | EXEL | 10-Q | Url |
| 2013-05-07 | 939767 | EXEL | 10-Q | Url |
| 2013-02-21 | 939767 | EXEL | 10-K | Url |
| 2012-11-07 | 939767 | EXEL | 10-Q | Url |
| 2012-08-02 | 939767 | EXEL | 10-Q | Url |
| 2012-05-03 | 939767 | EXEL | 10-Q | Url |
| 2012-02-22 | 939767 | EXEL | 10-K | Url |
| 2011-10-27 | 939767 | EXEL | 10-Q | Url |
| 2011-08-04 | 939767 | EXEL | 10-Q | Url |
| 2011-05-03 | 939767 | EXEL | 10-Q | Url |
| 2011-02-22 | 939767 | EXEL | 10-K | Url |
| 2010-11-04 | 939767 | EXEL | 10-Q | Url |
| 2010-08-05 | 939767 | EXEL | 10-Q | Url |
| 2010-05-11 | 939767 | EXEL | 10-Q | Url |
| 2010-03-10 | 939767 | EXEL | 10-K | Url |
| 2009-10-29 | 939767 | EXEL | 10-Q | Url |
| 2009-07-30 | 939767 | EXEL | 10-Q | Url |
| 2009-05-07 | 939767 | EXEL | 10-Q | Url |
| 2009-03-10 | 939767 | EXEL | 10-K | Url |
| 2008-10-27 | 939767 | EXEL | 10-Q | Url |
| 2008-08-05 | 939767 | EXEL | 10-Q | Url |
| 2008-07-07 | 939767 | EXEL | S-1 | Url |
| 2008-05-06 | 939767 | EXEL | 10-Q | Url |
| 2008-02-25 | 939767 | EXEL | 10-K | Url |
| 2007-11-05 | 939767 | EXEL | 10-Q | Url |
| 2007-08-07 | 939767 | EXEL | 10-Q | Url |
| 2007-05-03 | 939767 | EXEL | 10-Q | Url |
| 2007-02-27 | 939767 | EXEL | 10-K | Url |
| 2006-11-06 | 939767 | EXEL | 10-Q | Url |
| 2006-08-08 | 939767 | EXEL | 10-Q | Url |
| 2006-05-09 | 939767 | EXEL | 10-Q | Url |
| 2006-03-09 | 939767 | EXEL | 10-K | Url |
| 2005-11-03 | 939767 | EXEL | 10-Q | Url |
| 2005-08-09 | 939767 | EXEL | 10-Q | Url |
| 2005-05-09 | 939767 | EXEL | 10-Q | Url |
| 2005-03-15 | 939767 | EXEL | 10-K | Url |
| 2004-11-08 | 939767 | EXEL | 10-Q | Url |
| 2004-08-05 | 939767 | EXEL | 10-Q | Url |
| 2004-05-04 | 939767 | EXEL | 10-Q | Url |
| 2004-02-20 | 939767 | EXEL | 10-K | Url |
| 2003-11-05 | 939767 | EXEL | 10-Q | Url |
| 2003-08-06 | 939767 | EXEL | 10-Q | Url |
Exelixis, Inc(NASDAQ:EXEL) 
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who receiv...
Website: http://www.exelixis.com
Founded: 1994
Full Time Employees: 617
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about EXEL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.